The closest research and development to patients, active physicians and university hospitals that there is.






The closest research and development to patient, active physicians and university hospitals that there is.

Clinical Excellence & Impact

Clinical Excellence & Impact

We are involved with Scandinavian University Hospitals in digestive research that changes patients' quality of life today, rather than in the far future.

We are involved with Scandinavian University Hospitals in digestive research that changes patients' quality of life today, rather than in the far future.
We are involved with Scandinavian University Hospitals in digestive research that changes patients' quality of life today, rather than in the far future. Recently also with Greek University Hospitals.
Medical Leadership

The gastroenterologists on board are some of the more reputed in Europe. 

The gastroenterologists on board are some of the more reputed in Europe. 

Patient Advocacy

Our work is so patient centric that it is hosted and embraced by patient advocacy groups.

Our work is so patient centric that it is hosted and embraced by patient advocacy groups.

We are very close to the patients and their needs, and to Doctors and their needs, literarily. 

We are very close to the patients and their needs, and to Doctors and their needs, literarily. 

We are very close to the patients and their needs, and to Doctors and their needs, literarily. 

Our Story

Starting my career as a medical rep promoting Daiichi Sankyo’s Combizym, a pancrealase product, I witnessed first-hand about brands being pulled off the market and the impact the shortages had on patients.

In 2014, I co-developed Enzymax Forte and Enzymax Dou-Biotics based on the simple concept of moving digestive enzymes treatment to the stomach using acid-resistant enzymes.

Enzymax was a wellness product experiment, VentraZym is the clinical improvement designed for chronic use.

Smarter formulation, more capsules per box, more studies, and most importantly co-developed and endorsed by reputed Gastroenterologists.

Starting my career as a medical rep promoting Daiichi Sankyo’s Combizym, a pancrealase product, I witnessed first-hand about brands being pulled off the market and the impact the shortages had on patients.

In 2014, I co-developed Enzymax Forte and Enzymax Dou-Biotics based on the simple concept of moving digestive enzymes treatment to the stomach using acid-resistant enzymes.

Enzymax was a wellness product experiment, VentraZym is the clinical improvement designed for chronic use.

Smarter formulation, more capsules per box, more studies, and most importantly co-developed and endorsed by reputed Gastroenterologists.

Bassam Nasreddine Karout 

Bassam Nasreddine Karout 

Brand Logo
Brand Logo
Brand Logo
Brand Logo
Brand Logo
Brand Logo
Brand Logo
Brand Logo
Brand Logo
Brand Logo
Brand Logo
Brand Logo

Bassam Nasreddine Karout 

Our Partnership with Ask Pharma

We, at ASK Pharma family have been helping (in every sense) the global Cystic Fibrosis community. Availing treatments that makes their life more dignified and less burdensome, getting technologies reimbursed for the first time.

Our two generation stable success is based on genuine empathy, as anyone in the european CF community can confirm.

We joined this project because cystic fibrosis community are one of the highest consumers per pill daily of digestive enzymes. Also, their digestive tract is around 2 degrees more acidic, making VentraZym (activity starts at pH 2.8) particularly ideal.

Together with Milltons, we are shaking things up.

We, at ASK Pharma family have been helping (in every sense) the global Cystic Fibrosis community. Availing treatments that makes their life more dignified and less burdensome, getting technologies reimbursed for the first time.

Our two generation stable success is based on genuine empathy, as anyone in the european CF community can confirm.

We joined this project because cystic fibrosis community are one of the highest consumers per pill daily of digestive enzymes. Also, their digestive tract is around 2 degrees more acidic, making VentraZym (activity starts at pH 2.8) particularly ideal.

Together with Milltons, we are shaking things up.

The Kondyli family

The Kondyli family

Brand Logo
Brand Logo
Brand Logo

The Kondyli family

A Commitment to Stability

A Commitment to Stability

Unlike traditional animal-based extractions, Ventrazym’s laboratory-controlled fermentation process allows for scalable, consistent supply chains immune to the biological variances of livestock.

The closest research and development to patient, active physicians and university hospitals that there is.

A Commitment to Stability

Unlike traditional animal-based extractions, Ventrazym’s laboratory-controlled fermentation process allows for scalable, consistent supply chains immune to the biological variances of livestock.